[Four regions 12-core systemic prostate biopsy for diagnosis of prostate cancer].
OBJECTIVE
To evaluate the clinical value of the four regions 12-core systemic prostate biopsy.


METHODS
Ninety-one patients suspected of prostate cancer received four regions 12-core systemic prostate biopsy, and the detection rate and complications were compared with those of the sextant method.


RESULTS
More positive results were obtained in detecting prostate cancer with the four regions 12-core method, and the complications were similar to those of the sextant biopsy.


CONCLUSIONS
The four regions 12-core biopsy was suggested for patients suspected of prostate cancer with enlarged prostate gland above 40 ml.
Wu
Rongpei
R
Department of Urology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510080, China. pacemaker@21cn.com
Zheng
Keli
K
Li
Xiaofei
X
Zhong
Wanmei
W
D000368:Aged; D000369:Aged, 80 and over; D001707:Biopsy, Needle / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D011467:Prostate / Q000473:pathology*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000473:pathology